LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes

LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related Genes

Breast cancer (BRCA) is a serious public health problem, as it is the most frequent malignant tumor in women worldwide. BRCA is a molecularly heterogeneous disease, particularly at gene expression (mRNAs) level. Recent evidence shows that coding RNAs represent only 34% of the total transcriptome in...

Full description

Bibliographic Details
Main Authors: Mireya Cisneros-Villanueva, Lizbett Hidalgo-Pérez, Alberto Cedro-Tanda, Mónica Peña-Luna, Marco Antonio Mancera-Rodríguez, Eduardo Hurtado-Cordova, Irene Rivera-Salgado, Alejandro Martínez-Aguirre, Silvia Jiménez-Morales, Luis Alberto Alfaro-Ruiz, Rocío Arellano-Llamas, Alberto Tenorio-Torres, Carlos Domínguez-Reyes, Felipe Villegas-Carlos, Magdalena Ríos-Romero, Alfredo Hidalgo-Miranda
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Oncology
Subjects:
LINC00460
breast cancer
basal-like
biomarker
increased prognosis
mir-103a
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.628027/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.628027/full

Similar Items